Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Broadie
    Member
    • Oct 2009
    • 15

    Running assisted assemblies with runAssembly

    Hello,

    I am trying to figure out how to run an assisted assembly with runAssembly. I have been told that you can give runAssembly fasta files in addition to the sff files you want to assemble. I have a reference fasta and I tried giving this to run assembly in addition to the sff files and it skipped it:
    Warning: Long read Contig3893 (27001 bp) too long to be assembled. Skipping...

    Anyway to get runAssembly to assemble this? I suppose I could shred the fasta into shorter sequences into a multi fasta but that would somewhat defeat the purpose of doing an assisted assembly. Any help is appreciated.
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    #2
    Broadie,

    runAssembly is strictly a de novo assembly tool. It is true that you can also pass FASTA files to runAssembly but this is not to provide a reference, just additional, non-454 generated read data (e.g. Sanger sequence).

    To perform an assisted (mapping) assembly you need to use the program runMapping. You could also use the project based commands: newMapping, setRef, addRun, runProject, or you could use gsMapper (same underlying programs but with a GUI on top.)

    Comment

    • Tuxido
      Member
      • Jun 2009
      • 22

      #3
      The Roche mapping (or assembly) software uses a max of 2000bp for a read. So if you which to map reads that are longer than this (Contig3893) it will not run.

      So you should use another mapper program for this (we did it in CLCBio)

      Comment

      • waterboy
        Member
        • Oct 2010
        • 14

        #4
        Hello,
        Can any one please tell me how to use Newbler's scaffolder, I have contigs and 454 PE reads for scaffolding.

        I tried scaffolding using newbler gsAssembler, but I got the following warnings

        Warning: Long read single_contig1|size2654 (2654 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig2|size5564 (5564 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig4|size24776 (24776 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig5|size14460 (14460 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig6|size4969 (4969 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig7|size5569 (5569 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig8|size10954 (10954 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig9|size3906 (3906 bp) too long to be assembled. Skipping...
        Warning: Long read single_contig10|size5173 (5173 bp) too long to be assembled. Skipping...
        Warning: Input contains many reads too long to be assembled.

        Please guide me on these warnings and will you please tell me how you used Newbler scaffolder.

        Look forward to hearing from you.
        Last edited by waterboy; 08-25-2011, 09:25 PM.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...